Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 1,841 shares at $24.66 ($45K) on 2016-09-28, disclosed to the SEC on 2016-09-28.
Scheduled sale ($45k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-06-02 | $2.0M | — | Filing → |